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Efficacy of blood flow restriction exercise
during dialysis for end stage kidney disease
patients: protocol of a randomised
controlled trial
Matthew J. Clarkson1, Steve F. Fraser1, Paul N. Bennett2,3, Lawrence P. McMahon4, Catherine Brumby4
and Stuart A. Warmington1*
Abstract
Background: Exercise during haemodialysis improves strength and physical function. However, both patients and
clinicians are time poor, and current exercise recommendations add an excessive time burden making exercise a
rare addition to standard care. Hypothetically, blood flow restriction exercise performed during haemodialysis can
provide greater value for time spent exercising, reducing this time burden while producing similar or greater
outcomes. This study will explore the efficacy of blood flow restriction exercise for enhancing strength and physical
function among haemodialysis patients.
Methods: This is a randomised controlled trial design. A total of 75 participants will be recruited from
haemodialysis clinics. Participants will be allocated to a blood flow restriction cycling group, traditional cycling
group or usual care control group. Both exercising groups will complete 3 months of cycling exercise, performed
intradialytically, three times per week. The blood flow restriction cycling group will complete two 10-min cycling
bouts separated by a 20-min rest at a subjective effort of 15 on a 6 to 20 rating scale. This will be done with
pressurised cuffs fitted proximally on the active limbs during exercise at 50% of a pre-determined limb occlusion
pressure. The traditional cycling group will perform a continuous 20-min bout of exercise at a subjective effort of 12
on the same subjective effort scale. These workloads and volumes are equivalent and allow for comparison of a
common blood flow restriction aerobic exercise prescription and a traditional aerobic exercise prescription. The
primary outcome measures are lower limb strength, assessed by a three repetition maximum leg extension test, as
well as objective measures of physical function: six-minute walk test, 30-s sit to stand, and timed up and go.
Secondary outcome measures include thigh muscle cross sectional area, body composition, routine pathology,
quality of life, and physical activity engagement.
Discussion: This study will determine the efficacy of blood flow restriction exercise among dialysis patients for
improving key physiological outcomes that impact independence and quality of life, with reduced burden on
patients. This may have broader implications for other clinical populations with similarly declining muscle health
and physical function, and those contraindicated to higher intensities of exercise.
Trial registration: Australian and New Zealand Clinical Trial Register: ACTRN12616000121460.
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Background
End-stage kidney disease (ESKD) is the 5th stage of
chronic kidney disease, characterised by a failure of the
kidneys to adequately filter blood [1]. ESKD is estimated
to affect as many as 2 million people worldwide, ap-
proximately half of whom do not receive adequate treat-
ment [2, 3]. Treatment requires either transplantation,
or if transplantation is unavailable patients are solely re-
liant on regular dialysis [4]. Largely due to the regularity
of dialysis as a treatment, ESKD is among the most com-
mon reasons for hospitalisation [2]. However, despite
dialysis being considered one of the most efficacious
means of treating ESKD, it does not guarantee that life
can be sustained, with 12 month mortality rate following
initiation of dialysis estimated to be 10–12% [5].
ESKD patients suffer from anaemia, fatigue, muscle at-
rophy, decreased aerobic capacity, reduced participation
in physical activity, increased risk of falls, and decreased
quality of life [4, 6–8]. Patients with ESKD also demon-
strate significant decline in physical function and tasks
reflective of activities of daily living [9–13]. This dimin-
ished physical function leads to a significant loss of
independence with 95% of people with ESKD not fully
independent and in need of assistance with at least one
activity of daily living (ADL) [14]. This is more signifi-
cant considering that an inability to independently
complete ADLs is a major predictor of mortality for
ESKD [14]. Exercise is well tolerated among patients
with ESKD and is an efficacious method for ameliorating
these adverse symptoms characteristic of ESKD [15–18].
Heterogenous methodology, prescription and report-
ing among ESKD exercise studies make it difficult to
draft guidelines on the dosage and mode of exercise
training to derive the best outcomes for ESKD patients
[8, 19]. The current guidelines for exercise training with
ESKD recommend it encompasses aerobic (4 sessions;
45 mins), resistance (2 sessions; 20 mins), and flexibility
(7 sessions; 10 mins) exercise [20]. The cumulative time
commitment for these recommendations is substantial,
and would require training on both dialysis (during first
2 h of dialysis) and non-dialysis days [20]. However,
most randomised controlled trials examining exercise
regimens in ESKD have only utilised aerobic training,
most commonly stationary cycling [20]. Aerobic exercise
training alone does not traditionally increase strength
and hypertrophy, nor produce significant improvements
in physical function, all of which are needed among this
population [21].
Adherence to exercise training programs, regardless of
aerobic, resistance or combined modalities, is also poor
among ESKD patients, with more than 20% choosing
not to participate, citing issues such as lack of time, lack
of energy, too much trouble, and resistance training be-
ing too difficult [22]. Of those that chose to participate
in exercise training, the dropout rate was more than 25%
for programs utilising exercise training on non-dialysis
days [22]. While there is still an increased dropout rate
among patients with ESKD when exercise is completed
intradialytically (approximately 17%) [22], it is lower than
that seen on non-dialysis days. This suggests that intradia-
lytic exercise is still preferable with regards to participant
retention than exercise on non-dialysis days.
Resistance training poses further complications in the
setting of a dialysis unit as the required equipment is
cumbersome, and poses a high risk for cross-infection.
Less cumbersome washable elastic resistance bands may
be one option [23]. Exercise training during dialysis also
needs to be completed in the first 2 h of dialysis
sessions [24]. Therefore, finding a solution that may
provide improvements in all key outcomes as efficiently
as possible, allowing for completion during dialysis
would be preferable.
Blood flow restriction exercise training uses pres-
surised cuffs fitted proximally on the active limbs during
exercise training, and can elicit the above benefits at
lower exercise intensities than non- blood flow restric-
tion training [25, 26]. Blood flow restriction may be one
method for achieving outcomes reflective of both resist-
ance, and aerobic exercise training while providing an
efficient, simple exercise prescription model in the dialysis
setting. Blood flow restriction aerobic exercise training has
been shown to increase muscle size and strength more
than equivalent-intensity non-blood flow restriction aer-
obic exercise training, while still providing comparable or
greater improvements in cardiovascular fitness [25, 27, 28].
While blood flow restriction exercise training is used
predominately in single joint isolation resistance training
exercises such as knee extension, it has also been applied
during aerobic exercise training such as walking or
cycling [25, 29–32]. Common blood flow restriction
aerobic exercise training protocols utilise short exercise
durations of 10 to 20 min [25, 32–34]. Such studies utilis-
ing blood flow restriction with aerobic exercise training
have demonstrated increases in lower limb muscle volume
and strength of up to 8% and 16%, respectively [25, 32, 33].
However, it should be noted that without blood flow re-
striction, low-intensity aerobic exercise training is generally
insufficient to increase muscle volume or strength, unless
there is previous muscle atrophy or the initial level of
participant physical activity is extremely low [35]. Even in
such instances, improvements in muscle volume and
strength are unlikely to be of similar magnitude as seen
with blood flow restriction [35].
Regardless of the presence of blood flow restriction,
aerobic exercise training improves aerobic fitness pro-
vided that the exercise is of sufficient intensity [36].
Indeed, studies have demonstrated that low-to-moderate
intensity blood flow restriction aerobic exercise training
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is able to increase aerobic capacity when exercising at
intensities equivalent to 40% of peak exercise oxygen
consumption (⩒O2peak) [32, 33, 37].
Studies examining the haemodynamic responses to
blood flow restriction identify blood flow restriction aer-
obic exercise training as having lower haemodynamic
stress than high intensity resistance training, while pro-
viding similar outcomes [38–40]. As such, blood flow re-
striction is purported to be a potentially beneficial
addition to exercise for clinical populations who may be
contraindicated to high-intensity resistance training.
While blood flow restriction exercise is a novel addition
to exercise among ESKD patients, pilot data from this
laboratory (unpublished) indicates that haemodynamic
responses (systolic blood pressure, diastolic blood pres-
sure, mean arterial pressure, heart rate) do not differ
markedly between low-intensity blood flow restriction
and non-blood flow restriction aerobic exercise both
performed during haemodialysis in this population.
Aerobic capacity and muscle strength are both key
physiological factors underpinning physical function [41]
and both can improve with blood flow restriction aer-
obic exercise training. As declines in physical function,
muscle strength, and aerobic capacity, as well as acceler-
ated muscle atrophy are common among patients with
ESKD, blood flow restriction aerobic exercise training
may present an opportunity to increase the efficiency of
time spent exercising for this population.
This study will examine the efficacy of blood flow
restriction aerobic training among patients with ESKD
on haemodialysis (HD). We hypothesise that blood flow
restriction aerobic exercise training will improve physical
function, muscle strength, and muscle size among patients
with ESKD beyond that of traditional aerobic exercise
training.
Methods
Design
This is a 12-week randomised controlled trial consisting
of three groups randomised to exercise or usual care
(Fig. 1). Participants will be randomised to one of three
groups: a blood flow restriction cycling exercise training
group (BFR-C), a non-blood flow restriction cycling
exercise training group (CYC), or a non-exercising, usual
care control group (CON).
Sample size calculation
The most relevant outcome for blood flow restriction
training studies is knee extensor muscle strength, and
this was used as the main primary outcome measure for
calculating required sample size. Based on data from
previous blood flow restriction research [25, 29, 32, 33],
and previous exercise for ESKD research [18, 42, 43], the
projected percentage changes in knee extensor muscle
strength for each of the three groups are CON = −3%,
CYC = 2%, BFR-C = 12%. The common standard devi-
ation within group, based on the prior research was
determined to be 15. Thus, to achieve a power of 80% at
an α level of 0.05, 20 participants per group will be re-
quired to detect a difference between the expected
means for percentage strength improvement. However,
based on previous work conducted by this research
group a conservative attrition rate of 20% is expected
over 3 months due to voluntary patient withdrawal,
death, additional hospitalisation, transfer to another
facility, or patients receiving transplants [23]. Thus, a
total of 75 participants will be recruited and randomly
allocated to one of the three groups.
Recruitment and screening of participants
Participants will be recruited through recommendation
and referral from treating physicians at a number of
dialysis clinics linked to a major public hospital service
in a large metropolitan Australian city. Additionally,
nurse unit manager recommendations and fliers briefly
outlining the study posted within the dialysis clinics will
be used to help identify prospective participants. Prospect-
ive participants will be screened initially face-to-face or via
telephone by a member of the research team. Following
this, confirmation from the treating physician will be
obtained if not implied by referral. Participants will be
required to provide written, informed consent prior to
participation in the study.
Inclusion and exclusion criteria
Eligible participants will be male and female stable chronic
(>3 months) haemodialysis patients aged between 18 and
80 years. Participants will be deemed medically eligible by
their treating physician before participation in the present
study. Participants will be excluded if they do not under-
stand English and are unable to complete or comprehend
the surveys or study documents; if within the previous
12 weeks they have participated in regular physical activity
or sport (>150 min.wk.−1) of moderate or greater intensity
[44], or structured resistance training (> 1 session.wk.−1);
if they have symptomatic peripheral vascular disease, limb
ischemia, untreated symptomatic cardiovascular disease,
or any other absolute contraindications to exercise train-
ing (such as musculoskeletal factors or neurological condi-
tions) that may affect their ability to perform physical
assessments or exercise training protocols in the present
study; if they are currently smokers; or if they are pregnant
or have required hospitalisation for non-dialysis reasons in
the 4 weeks prior to the study’s commencement. Patients
will also be deemed unable to exercise during individual
dialysis sessions if they present with fluid overload (> 5%
above dialysis base weight) as this can cause reduced car-
diovascular reserve [45]. Similarly, if patients have systolic
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blood pressure > 180 mmHg, or diastolic blood pres-
sure < 90 mmHg prior to exercise they will be deemed
unsuitable for exercise on that day (excluding the first
blood pressure reading before dialysis, which is known to
be unreliable) [46]. Of clinical concern is the known pro-
pensity for HD patients to become hypotensive (poten-
tially more so post-exercise) during dialysis [47]. Although
this is uncommon and our pilot data indicates this is not
exacerbated by blood flow restriction, to ensure the safety
of all patients they will be monitored for chest pain/dis-
comfort, dyspnoea, lower limb pain, symptoms of severe
hyper- or hypotension, and other signs of adverse events,
which will be reported to the ethics committee of both the
treating hospital and Deakin University.
Randomisation
Randomisation will be conducted at a participant level
prior to familiarisation and baseline testing, and will
randomise participants by blocks of 4 via a computer-
generated random number sequence by an independent
researcher. Blinding of intervention group to clinical
staff and participants will not be possible once the
intervention commences.
Fig. 1 Study Flow Chart. BFR-C – Blood flow restriciton cycling group; CYC – Traditional cycling group; CON – Usual care control group; LOP – Limb
occlusion pressure; 3RM LE – Three-repetition Maximum Leg Extension; 6MWT – 6 min walk test; STS30–30-s sit-to-stand test; TUG – Timed up and go;
pQCT – Peripheral Quantitative Computed Tomography; iDXA – Dual X-ray Absorptiometry; URR – Urea Reduction Ratio; Hb – Haemoglobin;
Alb – Albumin; K+ − Potassium; PTH – Parathyroid Hormone; PO4 – Phosphate; RPE – Rating of perceived exertion
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Exercise intervention
Exercise training sessions will occur intradialytically for
all exercising participants and will be completed within
the first 2 h of the session to avoid loss of exercise train-
ing quality [24, 48]. All sessions will be supervised by a
member of the research team. Exercise training sessions
will consist of cycle exercise for both BFR-C and CYC
groups. Both BFR-C and CYC groups will complete a
total volume of 20 min cycling at a relative intensity for
each participant to be dictated by rating of perceived
exertion (RPE), similar to previous exercise and ESKD
studies [17, 49, 50]. This will also be compared to mea-
surements of percentage age-predicted maximum heart
rate (APHRmax) in order to determine if targeted RPE
needs to be adjusted to account for potential discrepan-
cies between patient subjective intensity and objectively
observed intensity. If participants are unable to maintain
the prescribed cadence at this workload for the full
duration, they will be instructed to complete as much of
each cycling bout as possible.
Age-predicted maximum heart rate
APHRmax will be used as a relative indicator of intensity
during exercise training sessions. Approximately 50–70%
of participant’s age-predicted APHRmax will be used as
an objective target to indicate whether participants in
BFR-C or CYC are exercising at the prescribed intensity
for this study. This will be achieved using a fingertip
heart rate monitor and pulse oximeter (CMS50, Contec
Medical Systems Co., Ltd., Qinhuangdao, Hebei Province,
China) placed on the second or third finger of the partici-
pant’s hand on the contralateral limb to their arterioven-
ous fistula. This will be measured and recorded during the
final minute of each period of active cycling within a
session to correspond with measures of RPE.
Blood flow restriction cycling group
The BFR-C group will complete an intermittent protocol
of 10 min cycling, 20 min rest, 10 min cycling. During
these sessions, participants in the BFR-C group will have
a blood flow restriction cuff fitted to the proximal end of
each thigh, which will be inflated continuously at 50% of
a pre-determined limb occlusion pressure (LOP)
throughout the full duration of cycling. Participants will
be required to cycle at an RPE of 15 (‘Hard’ on the Borg
6 to 20 scale [51]), expected to be equivalent to at least
60% of APHRmax for each 10 min cycling period. The
prescribed volume and intensity represents a balance be-
tween prior blood flow restriction protocols and those
utilised in the aerobic training components of HD
studies, while accounting for potentially very low levels
of physical function among the participants [6, 8, 52].
Blood flow restriction procedure
Blood flow restriction will be applied using an automatic
tourniquet system (A.T.S 3000, Zimmer Inc., OH, USA).
The ATS produces a defined, controlled pressure via
adjustable pneumatic cuffs (52 cm long, 10.5 cm wide;
bladder length 45 cm, bladder width 8 cm). The pressure
is regulated to control for changes in muscle contractile
pressures under the cuff in such a way that the occlusive
pressure applied to the limb is constant.
The cuffs will be applied to the proximal aspect of the
thigh prior to commencing exercise, and gradually in-
flated, as detailed by Abe et al. (2006) [25]. Blood flow
restriction pressure will be set at 50% of pre-exercise
resting LOP. LOP will be calculated during a familiarisa-
tion session for participants allocated to the BFR-C
group using a digital plethysmograph (Pulse Sensor,
Zimmer ATS 3000) applied to the second toe [40, 53]. A
seated or recumbent posture will be used for LOP as it
most closely matches the posture that will be used dur-
ing the exercise training sessions. To determine LOP, the
pneumatic cuffs are inflated to the point at which the ple-
thysmograph can no longer detect blood flow to the toe
(blood flow completely occluded). This will be done for
each leg and repeated to ensure accuracy (<20 mmHg),
and an average of these measures will be taken. The 50%
LOP that is to be applied during exercise training sessions
does not fully occlude the limb in this manner, and allows
for continuous blood flow during exercise.
Cycling group
The CYC group exercise training sessions will require
20 min continuous cycling at an equivalent intensity to
the BFR-C group. However due to the absence of blood
flow restriction, the equivalent intensity is often reported
to have a lower RPE and mildly reduced heart rate re-
sponse, regardless of exercise modality [38, 54, 55]. As
such, the target RPE will be 12 (‘light to somewhat hard’
on the Borg 6 to 20 scale [51]) for the CYC group, which
is expected to equate to at least 50% APHRmax. This in-
tensity is recommended for intradialytic aerobic exercise
in the Exercise and Sport Science Australia (ESSA) pos-
ition statement on exercise for chronic kidney disease
[20]. This volume is reflective of protocols used by other
studies examining exercise training among patients with
ESKD, and represents a “normal” exercise training
prescription for patients with ESKD [22, 56].
Progression
In order to ensure that training sessions maintain a suffi-
cient intensity for all exercising participants, resistance
applied to the pedals, cadence, or a combination of both
variables will be adjusted on a session-by-session basis
by a trained exercise physiologist such that the required
RPE target (indicative of sufficient subjective intensity) is
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achieved. This accounts for any illness or excessive fa-
tigue that may affect exertion during any given session.
A rolling two-week average of RPE will be monitored
(on the 6–20 Borg’s RPE scale [51]) to ensure progres-
sive overload is being achieved over the course of the 3-
month intervention.
Usual care control group
Participants allocated to the usual care control group will
receive no additional access to exercise training and will re-
ceive minimal advice regarding exercise training through-
out the study. Participants randomised to the usual care
control group will be given access to an accredited exercise
physiologist member of the research team, free of charge if
they would like to discuss the benefits of commencing
exercise training upon completion of the study.
Data collection
Data collection will occur at baseline (T1) and 12 weeks
(T2), with testing to be completed at the treating HD
unit prior to the commencement of the participants’ HD
session. Personal information, including relevant medical
history will be collected prior to the initiation of testing
or intervention upon receiving participant consent. This
will include patient characteristics of age, gender, time in
months that the participant has been receiving HD
(dialysis vintage), basic anthropometric measures
(height, weight, and BMI), relevant comorbidities and
medications, transplant status, and type of dialysis ac-
cess. Some or all of which may be taken, with approval,
from the case file at the HD unit. The remaining data
collected will include all measures of muscle function
and physical function. Body composition scans will be
performed on a non-dialysis day, separate from other
testing procedures for participants who opt-in to this as-
pect of testing. Additional pathology measurements will
include haemoglobin, albumin, potassium, parathyroid
hormone, phosphate, urea reduction ratio (URR), creat-
ine kinase and lactate. These measures will occur as part
of routine pathology tests where possible, or will be re-
quested out-of-cycle to coincide with the necessary
period of the training intervention. Data will be coded
and stored securely at Deakin University. Data collected
from those who withdraw from the study will not be
used for statistical analyses. This has been accounted for
when completing the power analysis, with an additional
20% added to the target sample size. Attrition may be
for a number of reasons, which will be ascertained upon
withdrawal where possible.
Primary outcome measures
Lower-limb muscle strength
Maximal lower limb muscle strength will be determined
using three-repetition maximum (3RM) knee extension
(HS-LE, Life Fitness, Victoria, Australia) [57]. A 3RM knee
extension test measures the maximum weight that can be
lifted for three consecutive repetitions of a knee extension
exercise with good technique and full range of motion. The
3RM result will be input into a formula to derive equivalent
one-repetition maximum for each participant [58].
Physical function
Objective physical function will be measured using the
30-s sit to stand test (STS30), the timed up and go test
(TUG), and the six-minute walk test (6MWT).
The STS30 measures lower limb muscle strength and
function and requires participants to stand from a chair
and then return to the seated position as many times as
possible in 30 s [59]. The test has also displayed strong
comparative validity to lower extremity 1RM strength test-
ing, particularly among community-dwelling older adults
[59]. It has also demonstrated a high level of reliability
among ESKD patients undergoing HD (ICC = 0.93) [60].
The TUG is a measure of dynamic balance and mobil-
ity requiring participants to stand from a chair, walk to
and then around a cone placed 3 m away, walk back to
the chair, and sit back down as quickly as possible. This
test will be repeated three times, and an average time taken
for accuracy purposes [61]. The TUG strongly reflects gait
speed among older adults, and has shown strong test re-
test reliability not only among older adults, but in ESKD
patients undergoing HD (ICC = 0.91–0.96) [62–64].
The 6MWT is a self-paced assessment of aerobic cap-
acity, and a strong index of all cause morbidity in older
adults [65]. It requires participants to walk laps of a
straight 30 m course with the objective to cover as much
distance as possible in the six-minute duration [65]. The
6MWT is a reliable measure for patients with ESKD
(ICC = 0.93–0.96) [60, 66]. It has also been validated
against ⩒O2max for patients with ESKD, with moderate
strength coefficients of correlation (r = 0.56–0.73) [11, 67].
Secondary outcome measures
Muscle cross-sectional area and body composition
Total and regional body composition (lean mass, fat
mass and percentage fat mass) will be assessed using
iDXA (Lunar iDXA, GE Healthcare, Madison, WI).
Muscle cross-sectional area around the femur diaphysis
at 25% and 50% of femur length will be assessed using
pQCT (XCT 3000, Stratec Medizintechnik, Baden-
Württemberg, Germany), allowing for knee flexor and
extensor musculature to be measured. Height and body
mass will be assessed using a portable stadiometer and
scales respectively.
Pathology measures
Pathology measurements will be taken during routine
collections completed by the treating hospital. The
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exercise intervention will be timed such that these rou-
tine pathology measures occur within the 4 weeks prior
to the commencement of the first training session (or
prior to the 3 month usual care monitoring period for
the CON). These additional measures will include
haemoglobin, albumin, potassium, parathyroid hormone,
and phosphate. URR will also be measured by the treat-
ing hospital as a part of patients’ quarterly pathology
tests, providing it is within the 4 weeks prior to patients
commencing their exercise intervention. If this cannot
be achieved in a timely manner, an additional measure
of URR will be requested for a single dialysis session
prior to the commencement of the exercise intervention.
Two additional measures of URR, creatine kinase and
lactate will also be required outside of the normal regi-
men for patients in either of the exercise training inter-
vention groups, once during the first week of the
exercise training intervention, and again during the final
week of the exercise training intervention. An additional
out-of-cycle measure of URR will also be required by
participants in the usual care control group, unless this
is scheduled to be completed within 2 weeks following
their 3-month monitoring period for this study as a part
of their quarterly routine pathology test. All measures
are conducted at the beginning and upon completion of
a single dialysis session to establish the difference in
each marker over the course of that session. This will
allow analysis of the impact of exercise and specific
exercise intervention types (BFR-C and CYC) on dialysis
adequacy, as well as providing objective proof that there
is no major tissue damage as a result of the intervention.
Physical activity levels
The Community Healthy Activities Model Program for
Seniors (CHAMPS) physical activity survey will be used
to assess participation in a comprehensive list of low,
moderate and vigorous physical activities [68]. This
questionnaire will provide valuable information about
changes in physical function and physical activity behav-
iour over the course of the study.
Symptom related quality of life
The POS-S Renal questionnaire will be given to patients
during the familiarisation session to assess their quality
of life in direct relation to the symptoms experienced as
a part of their condition [69]. This questionnaire pro-
vides valuable feedback about any changes experienced
by patients regarding quality of life and disease-specific
symptoms as a result of the intervention.
Statistical analysis
All statistical analyses will be performed using SPSS 22.0
(IBM Corp, Chicago IL, United States of America).
Participant characteristic and demographic data will be
presented using descriptive statistics, and compared using
independent t-tests for continuous variables and chi-
square tests for categorical variables. The distribution of
data will be assessed for normality with a Shapiro-Wilks
test (P > 0.05). Non-normally distributed data will be com-
pared using the Friedman non-parametric test. Otherwise,
comparisons between groups for all continuous primary
and secondary variables measured will be made using
one-way analysis of variance (ANOVA). Main effects will
be analysed using a Tukey post hoc test. A significance
level of P < 0.05 will be adopted for all statistical tests. All
data will be presented as means ± SEM unless stated.
Discussion and conclusion
This study is the first to explore the efficacy of blood
flow restriction aerobic exercise training among patients
with ESKD. Additionally, it is one of the first to explore
a battery of common clinical measures or physical func-
tion following a blood flow restriction aerobic exercise
training program. The main objective of the study is to
determine the effectiveness of blood flow restriction
aerobic exercise training for improving the strength and
physical function among patients with ESKD.
While exercise during dialysis is not a novel concept
in the broader literature, the current exercise recom-
mendations present a significant time and physical bur-
den for patients with ESKD and does not have an
established role in clinical practice. Therefore, this study
is important given the well documented deficits in
strength and physical function for patients with ESKD in
conjunction with the rarity with which any exercise is
adopted not only intradialytically, but in the broader
ESKD population. It may also be valuable to include
measures related to vascular stiffness (e.g. pulse wave
velocity and vascular-related microRNAs), as this has
also been shown to improve with exercise training,
and may be enhanced with the addition of blood flow
restriction [34, 70, 71].
It is expected that this study will provide an improved
understanding of the role that blood flow restriction
aerobic exercise training can play in providing an effica-
cious, time-efficient modality of intradialytic exercise for
patients with ESKD, which caters to the population’s lower
initial level of physical function and overall conditioning.
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